
PODNYX CV 50 Oral Suspension by Kivonyx Healthcare Pvt. Ltd. contains Cefpodoxime and Potassium Clavulanate, a prescription antibiotic combination intended for selected bacterial infections caused by susceptible microorganisms. Cefpodoxime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Potassium Clavulanate inhibits certain beta-lactamase enzymes associated with antibiotic resistance. PODNYX CV 50 may be prescribed for selected respiratory tract, ear, throat, urinary tract, and skin infections when the specific combination is approved and clinically appropriate. Supplied as a dry powder for reconstitution into a 30 ml oral suspension, the formulation provides a convenient administration option for eligible paediatric patients. Treatment should follow a paediatrician's prescription, considering body weight, bacterial susceptibility, allergy history, kidney function, and recommended duration.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.